5Vote!
Medical News Today (Free subscription) | yesterday
Boston Scientific Corporation (NYSE: BSX) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
3Vote!
DeviceSpace (Free subscription) | yesterday
Medical-products manufacturer Boston Scientific will close its plant in Doral, Fla., eliminating 1,400 jobs by 2012, Miami-Dade economic development officials said Friday. The company is transferring the plant's work to a vacant facility in Costa Rica, where labor costs are much lower, said Frank Nero, president of the Beacon Council, Miami-Dade County's economic development agency.
3Vote!
Medgadget (Free subscription) | 23/11/2009
Boston Scientific has announced that its WallFlex® Fully Covered Esophageal Stent received 510(k) clearance from the FDA as well as EU's CE Mark of approval. The stent is designed for esophageal strictures caused by cancer of the esophagus. The use of stents can re-open a blocked esophagus, allowing patients to consume solids and liquids once again. More from the press release: The WallFlex Fully...
3Vote!
The Industry Standard (Free subscription) | 23/11/2009
Boston Scientific wants to tear down barriers that prevent product developers from accessing the research that went into its successful medical devices so that they can create new products faster. But making data too easily accessible could open the way to theft of information potentially worth millions or billions of dollars. It's a classic corporate data privacy problem. "The more info you...
3Vote!
MassDevice - Medical device news, information and jobs... (Free subscription) | 23/11/2009
Boston Scientific Corp. plans to shutter a plant in Doral, Fla., laying off 1,400 workers as it moves the operation to Costa Rica. Boston Scientific Corp. (NYSE:BSX) plans to shutter a plant in Doral, Fla., laying off 1,400 workers, The Miami Herald reported. The Natick, Mass.-based medical devices giant is relocating the Doral operation to a vacant facility in Costa Rica beginning next year, according...
3Vote!
Drug and Device Law (Free subscription) | 23/11/2009
Here's today's question: What do we think of McQuiston v. Boston Scientific Corp., No. 5:07-cv-01723-TS-MLH, slip op. (W.D. La. Nov. 19, 2009) ( link here )? Here's today's answer: We love it! But not for the reasons you'd think. Here's the deal: On September 1, 2006, Dr. Thomas Brown performed an angioplasty and stent procedure on James McQuiston. Boston Scientific manufactured the stent. McQuiston...
3Vote!
TinyTechIP (Free subscription) | 23/11/2009
http://www.freepatentsonline.com/7618647.html " Buckypaper " is used to refer to an entangled mat of carbon nanotubes. This patent from Boston Scientific Scimed includes some basic claims to using buckypaper as a biocompatible and high-strength coating for medical implants such as stents. Claim 1 reads: 1. A medical implant system comprising: a medical implant having an exterior surface;...
3Vote!
The South Florida Business Journal (Free subscription) | 21/11/2009
Medical products company Boston Scientific Corp., which has more than 1,200 employees working out of a 14-acre plant in Doral, is relocating its operation to Costa Rica over the next three years.
3Vote!
Miami Herald (Free subscription) | 21/11/2009
Medical-products manufacturer Boston Scientific will close its plant in Doral, eliminating 1,400 jobs by 2012, Miami-Dade economic development officials said Friday.
3Vote!
Miami Herald (Free subscription) | 20/11/2009
Medical-products manufacturer Boston Scientific will close its plant in Doral, eliminating 1,400 jobs by 2013, Miami-Dade economic development officials announced Friday afternoon.
3Vote!
MassDevice - Medical device news, information and jobs... (Free subscription) | 20/11/2009
Boston Scientific Corp. won CE Mark approval in the European Union and 510(k) clearance from the Food & Drug Administration for its WallFlex fully covered esophageal stent. Boston Scientific Corp. (BSX) won 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval for its WallFlex fully covered esophageal stent. The Natick, Mass.-based medical devices monolith's latest stent...
Videos